Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP30663 Intravenous Cardioversion in Atrial Fibrillation
2018-004445-17Phase 2Completed
- Sponsor
- Acesion Pharma
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Atrial fibrillation (AFib) comparing AP30663 intravenous with Placebo intravenous (2 arms). Started Apr 2019; status: completed.
02
Drugs
AP30663
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2018-004445-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004445-17.